×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TNYA – tenaya therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TNYA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
11:57 pm
tnya
Tenaya Therapeutics: Risky But Promising Cardiac Gene Platform [Seeking Alpha]
Low
Report
Tenaya Therapeutics: Risky But Promising Cardiac Gene Platform [Seeking Alpha]
11/10
03:21 pm
tnya
Tenaya Therapeutics (NASDAQ:TNYA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $9.00 price target on the stock.
Low
Report
Tenaya Therapeutics (NASDAQ:TNYA) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $9.00 price target on the stock.
11/10
03:12 pm
tnya
Tenaya Therapeutics, Inc. (TNYA) Shareholder/Analyst Call Transcript [Seeking Alpha]
Low
Report
Tenaya Therapeutics, Inc. (TNYA) Shareholder/Analyst Call Transcript [Seeking Alpha]
11/10
07:00 am
tnya
Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
High
Report
Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
11/8
02:14 pm
tnya
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy [Yahoo! Finance]
High
Report
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy [Yahoo! Finance]
11/8
11:25 am
tnya
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
High
Report
Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy
11/4
07:01 pm
tnya
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025 [Yahoo! Finance]
Low
Report
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025 [Yahoo! Finance]
11/4
05:30 pm
tnya
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025
Low
Report
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025
Date
Time
Symbol
Company Name
Action
%Chg
11/10/2025
07:00 am
TNYA
tenaya therapeutics, inc.
BEAT
Report
13.5%
tenaya therapeutics, inc.
Date
Time
Symbol
Headline
Impact
11/17
08:35 pm
tnya
Form 4 Tenaya Therapeutics, For: Nov 17 Filed by: Higa Tomohiro
Low
Report
Form 4 Tenaya Therapeutics, For: Nov 17 Filed by: Higa Tomohiro
11/17
08:34 pm
tnya
Form 4 Tenaya Therapeutics, For: Nov 17 Filed by: Tingley Whittemore
Low
Report
Form 4 Tenaya Therapeutics, For: Nov 17 Filed by: Tingley Whittemore
11/17
08:34 pm
tnya
Form 4 Tenaya Therapeutics, For: Nov 17 Filed by: Ali Faraz
Low
Report
Form 4 Tenaya Therapeutics, For: Nov 17 Filed by: Ali Faraz
11/10
07:12 am
tnya
Form 10-Q Tenaya Therapeutics, For: Sep 30
High
Report
Form 10-Q Tenaya Therapeutics, For: Sep 30
11/10
07:07 am
tnya
Form 8-K Tenaya Therapeutics, For: Nov 10
High
Report
Form 8-K Tenaya Therapeutics, For: Nov 10
11/7
04:24 pm
tnya
Form 8-K Tenaya Therapeutics, For: Nov 07
Medium
Report
Form 8-K Tenaya Therapeutics, For: Nov 07
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: